Conference item : Abstract
A phase 3, randomized, open-label study evaluating the safety and efficacy of magrolimab in combination with azacitidine in previously untreated patients with TP53-mutant acute myeloid leukemia
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
- Publisher:
- American Society of Hematology
- Journal:
- Blood More from this journal
- Volume:
- 138
- Issue:
- S1
- Pages:
- 3426-3427
- Publication date:
- 2021-11-23
- Event title:
- 63rd American Society of Hematology Annual Meeting and Exposition
- Event location:
- Atlanta, GA
- Event website:
- https://www.hematology.org/meetings/annual-meeting/past-and-upcoming-meetings
- Event start date:
- 2021-12-11
- Event end date:
- 2021-12-14
- DOI:
- EISSN:
-
1528-0020
- ISSN:
-
0006-4971
- Language:
-
English
- Keywords:
- Subtype:
-
Abstract
- Pubs id:
-
1277939
- Local pid:
-
pubs:1277939
- Deposit date:
-
2022-09-26
Terms of use
- Copyright holder:
- American Society of Hematology
- Copyright date:
- 2021
- Rights statement:
- © 2021 American Society of Hematology.
If you are the owner of this record, you can report an update to it here: Report update to this record